Cholinergic crisis

Global Healthcare Cold Chain Logistics Market Outlook & Forecasts Report 2023-2028: Technology Advancements Driving Competition - Blockchain Integration Elevating Industry Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, September 11, 2023
Health, Other Health, Vaccine, Workforce, Kuehne + Nagel, Deutsche Post DHL Group, FedEx, Center for Drug Evaluation and Research, AmerisourceBergen, Quick (restaurant), Internet of things, Clinical trial, Temperature, Transport, USD, DB Schenker, United Parcel Service, Counterfeit, DB Group, Ageing, Joint Medical Service (Germany), Developed country, Investment, Patient, Growth, API, CEVA Logistics, FDA, Cholinergic crisis, Nippon Express, Safety, Pharmaceutical industry, Warehouse, Research

The "Healthcare Cold Chain Logistics Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Healthcare Cold Chain Logistics Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • North America accounted for the highest revenue share of over 37% of the global healthcare cold chain logistics market in 2022.
  • The global healthcare cold chain logistics market is highly fragmented and concentrated, with many key players in the industry.
  • The pharmaceutical/biotech companies' end-user segment accounted for the highest revenue share of the global healthcare cold chain logistics market in 2022.

Global Single-use Filtration Assemblies Market Report 2023: Sector is Expected to Reach $11.8 Billion by 2030 at a CAGR of 18.7% - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 15, 2023
Biotechnology, Pharmaceutical, Health, Drug development, Therapy, Prevalence, TFF, Center for Drug Evaluation and Research, COVID-19, DFF, Cancer, Cross-flow filtration, Research, Immunology, USD, Sterilization, Risk, Filtration, Conditional sentence, Growth, ONS, Cholinergic crisis, FDA, Neurology, Safety, Sewage treatment, Fine chemical, Pharmaceutical industry

The global single-use filtration assemblies market size is expected to reach USD 11.8 billion by 2030.

Key Points: 
  • The global single-use filtration assemblies market size is expected to reach USD 11.8 billion by 2030.
  • The market is expected to expand at a CAGR of 18.70% from 2023 to 2030.
  • Single-use filtration assemblies offer several advantages over traditional filtration systems, such as reduced contamination risk, lower capital costs, and increased flexibility.
  • Membrane filtration sub segmented into TFF and direct flow filtration (DFF) /dead-end filtration /normal flow filtration.

New Drug Approvals and Their Contract Manufacture: 2023 Report - Detailed view of CDMO Performance by Number of Drug and Vaccine Approvals - ResearchAndMarkets.com

Retrieved on: 
Friday, May 19, 2023
FDA, Pharmaceutical, Health, Table, Alzheimer's disease, Blas, COVID-19, NDA, CMOS, Contract manufacturing organization, Zenith Contract Services, CMO, Accelerated approval (FDA), NME, Shirin David, Cholinergic crisis, Society, Benchmarking, Pharmaceutical industry, Fine chemical, Aducanumab, Biogen

The "New Drug Approvals and Their Contract Manufacture - 2023 Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "New Drug Approvals and Their Contract Manufacture - 2023 Edition" report has been added to ResearchAndMarkets.com's offering.
  • In 2022, the FDA approved c100+ new drug applications (NDAs) and biologics license applications (BLAs).
  • New Drug Approvals and Their Contract Manufacture - 2023 Edition; is the 13th edition in the series of long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance.
  • New Drug Approvals and their Contract Manufacture (formerly called 'CMO Scorecard') is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs.